StrategyNavigating APP Credentialing and Privileging Laws
It becomes critical to have medical staff bylaws that adequately address the role of APPs and contemplate the various issues...
Covid-19As Problems Grow with Abbott's Fast COVID Test, FDA Standards are Under Fire
The FDA has now received a total of 106 reports of adverse events for the Abbott test.
FinanceWashington State Emergency Order Bans Surprise Lab Billing for COVID-19
The order aims to prevent surprise bills for lab fees related to medically necessary diagnostic testing for COVID-19 and is...
StrategyFTC, DOJ Seek Public Input on Vertical Merger Guidelines
The draft guidelines outline the agencies' analytical techniques, practices, and enforcement for vertical mergers.
Clinical CareDoctor and Patient Education Cuts PPI Use
Big drop in scripts after interventions in Texas program.
FinanceCMS Issues Final Rule on Hospital Price Transparency, Pushes Effective Date to 2021
After months of feedback from payers and providers unhappy with a proposal to mandate price transparency in healthcare, the Trump...
FinanceWhy Red Wyoming Seeks The Regulatory Approach To Air Ambulance Costs
The Cowboy State hopes to undercut the free market by using Medicaid to treat air ambulances like a public utility.
Clinical CareABIM to Launch 'Longitudinal' MOC Test
Physicians can choose between periodic brief assessments or single high-stakes exam.
Clinical CarePrior Authorization Fixes Still a Medicare Priority, Says CMS Chief
Process needs to be less burdensome, Verma says
NursingNurse Staffing at Nursing Homes is Lacking
Nursing homes only met nurse staffing requirements less than 60% of the time, a new analysis finds.
StrategyFlorida Repeals CON Law, and One Hospital CEO Cheers
Cleveland Clinic Florida CEO Wael Barsoum, MD, says removing the artificial barrier to competition will improve access to care and...
FDA Overlooked Red Flags In Drugmaker's Testing of New Depression Medicine
Spravato maker Janssen provided the FDA modest evidence that it worked and only in limited trials. It presented no information...